Managing the Psychosocial Complexities of Sickle Cell Disease with Multiple Comorbidities during Allogeneic Hematopoietic Stem Cell Transplantation with Supportive Nursing Care
In 1984, the first successful allogeneic hematopoietic stem cell transplantation (HSCT) was performed to manage sickle cell disease (SCD). Allogeneic hematopoietic stem cell transplantation remains the only curative treatment for sickle cell disease. Although allogeneic HSCT offers the potential for cure, it can cause a host of complications. These complications include infection, narcotic dependency, alloimmunization, sudden death, psychosocial complications, and transfusion dependency.Given these comorbidities and other underlying conditions, the transplant process poses unique difficulties and represents a heavy psychosocial burden for this patient population.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Anita Oko-Odoi Tags: 662 Source Type: research
More News: Biology | Nurses | Nursing | Sickle Cell Anemia | Stem Cell Therapy | Stem Cells | Transplants